+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp
  • ConMed Corp
  • F. Hoffmann-La Roche Ltd
  • Immunomedics Inc
  • MallInckrodt Plc
  • MORE
GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

GlaxoSmithKline Plc (GSK) is a healthcare company that focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervous system (CNS), metabolic, cardiovascular and urogenital, anti-bacterials, dermatology and rare diseases. The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases. GSK’s vaccine portfolio cover various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in Brentford, Middlesex, the UK.

GlaxoSmithKline Plc Key Recent Developments

Mar 21, 2019 GlaxoSmithKline targets regulatory filings by year end for antiBCMA drug GSK2857916 in multiple myeloma https[external URL] $GSK
Mar 18, 2019 Two-drug combos using popular calcium channel blocker show superiority in lowering blood pressure
Mar 11, 2019 NEW GENETIC DATA FROM REGENERON AND GSK ON 50, 000 UK BIOBANK PARTICIPANTS MADE AVAILABLE TO GLOBAL HEALTH RESEARCH COMMUNITY
Mar 11, 2019 New genetic data from Regeneron and GSK on 50, 000 UK Biobank participants made available to global health research community

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Boston Scientific Corp
  • ConMed Corp
  • F. Hoffmann-La Roche Ltd
  • Immunomedics Inc
  • MallInckrodt Plc
  • MORE
Section 1 - About the Company
  • GlaxoSmithKline Plc - Key Facts
  • GlaxoSmithKline Plc - Key Employees
  • GlaxoSmithKline Plc - Key Employee Biographies
  • GlaxoSmithKline Plc - Major Products and Services
  • GlaxoSmithKline Plc - History
  • GlaxoSmithKline Plc - Company Statement
  • GlaxoSmithKline Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • GlaxoSmithKline Plc - Business Description
  • Business Segment: Consumer Healthcare
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Pharmaceuticals
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Vaccines
  • Overview
  • Performance
  • Key Stats
  • Geographical Segment: Rest of World
  • Performance
  • Geographical Segment: The UK
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • GlaxoSmithKline Plc - Corporate Strategy
  • GlaxoSmithKline Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • GlaxoSmithKline Plc - Strengths
  • GlaxoSmithKline Plc - Weaknesses
  • GlaxoSmithKline Plc - Opportunities
  • GlaxoSmithKline Plc - Threats
  • GlaxoSmithKline Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • GlaxoSmithKline Plc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 21, 2019: GlaxoSmithKline targets regulatory filings by year end for antiBCMA drug GSK2857916 in multiple myeloma https[external URL] $GSK
  • Mar 18, 2019: Two-drug combos using popular calcium channel blocker show superiority in lowering blood pressure
  • Mar 11, 2019: NEW GENETIC DATA FROM REGENERON AND GSK ON 50,000 UK BIOBANK PARTICIPANTS MADE AVAILABLE TO GLOBAL HEALTH RESEARCH COMMUNITY
  • Mar 11, 2019: New genetic data from Regeneron and GSK on 50,000 UK Biobank participants made available to global health research community
  • Mar 04, 2019: California Life Sciences Association (CLSA) adds GlaxoSmithKline and Blade Therapeutics to Board
  • Feb 27, 2019: Study Identifies Predictors of Psychiatric Events During Drug-Assisted Smoking Cessation
  • Feb 18, 2019: GSK to divest Chiron Behring Vaccines to Bharat Biotech
  • Feb 06, 2019: GSK signs $4.2bn immunotherapy deal with Merck
  • Feb 06, 2019: GSK delivers sales, earnings and cash flow growth in 2018
  • Feb 05, 2019: Wellcome commits £10 million to DNDi to develop new generation of oral drugs to treat leishmaniasis
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • GlaxoSmithKline Plc, Key Facts
  • GlaxoSmithKline Plc, Key Employees
  • GlaxoSmithKline Plc, Key Employee Biographies
  • GlaxoSmithKline Plc, Major Products and Services
  • GlaxoSmithKline Plc, History
  • GlaxoSmithKline Plc, Other Locations
  • GlaxoSmithKline Plc, Subsidiaries
  • GlaxoSmithKline Plc, Joint Venture
  • GlaxoSmithKline Plc, Key Competitors
  • GlaxoSmithKline Plc, Ratios based on current share price
  • GlaxoSmithKline Plc, Annual Ratios
  • GlaxoSmithKline Plc, Annual Ratios (Cont...1)
  • GlaxoSmithKline Plc, Annual Ratios (Cont...2)
  • GlaxoSmithKline Plc, Interim Ratios
  • GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
  • GlaxoSmithKline Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • GlaxoSmithKline Plc, Performance Chart (2014 - 2018)
  • GlaxoSmithKline Plc, Ratio Charts
  • GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
  • GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Stryker Corp
  • Sanofi
  • Pfizer Inc
  • Novartis AG
  • Merck & Co Inc
  • Medtronic Plc
  • MallInckrodt Plc
  • L'Oreal SA
  • Kimberly-Clark Corporation
  • Immunomedics Inc
  • GlaxoSmithKline Plc
  • F. Hoffmann-La Roche Ltd
  • Eli Lilly and Co
  • ConMed Corp
  • Cardiovascular Systems Inc
  • C. R. Bard Inc
  • Boston Scientific Corp
  • Beiersdorf AG
  • Abbott Laboratories
Note: Product cover images may vary from those shown
Adroll
adroll